Production (Stage)
Camp4 Therapeutics Corporation
CAMP
$2.09
$0.105.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 49.32M | 64.04M | 2.53M | 12.61M | 38.38M |
| Total Receivables | 106.00K | 108.00K | 1.11M | 345.00K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 821.00K | 928.00K | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.43M | 1.31M | 1.87M | 1.83M | -- |
| Total Current Assets | 51.68M | 66.38M | 5.50M | 14.79M | -- |
|
|
|||||
| Total Current Assets | 51.68M | 66.38M | 5.50M | 14.79M | -- |
| Net Property, Plant & Equipment | 9.47M | 10.30M | 10.91M | 11.78M | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.62M | 1.62M | 4.95M | 3.38M | -- |
| Total Assets | 62.77M | 78.31M | 21.36M | 29.94M | -- |
|
|
|||||
| Total Accounts Payable | 1.40M | 1.21M | 3.87M | 1.46M | -- |
| Total Accrued Expenses | 1.84M | 4.30M | 3.68M | 2.93M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.21M | 3.17M | 3.28M | 3.39M | -- |
| Total Finance Division Other Current Liabilities | -- | 922.00K | 1.00M | -- | -- |
| Total Other Current Liabilities | -- | 922.00K | 1.00M | -- | -- |
| Total Current Liabilities | 6.44M | 9.60M | 11.83M | 7.79M | -- |
|
|
|||||
| Total Current Liabilities | 6.44M | 9.60M | 11.83M | 7.79M | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.76M | 5.56M | 6.36M | 7.12M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.00K | 2.00K | 2.00K | 2.00K | -- |
| Total Liabilities | 11.20M | 15.16M | 18.19M | 14.91M | -- |
|
|
|||||
| Common Stock & APIC | 275.76M | 274.90M | 39.50M | 37.88M | -- |
| Retained Earnings | -224.19M | -211.75M | -198.47M | -184.99M | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 51.57M | 63.14M | -158.98M | -147.11M | -123.73M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | 162.15M | 162.15M | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | 162.15M | 162.15M | 162.15M |
|
|
|||||
| Total Common Equity | 51.57M | 63.14M | -158.98M | -147.11M | -123.73M |
| Total Preferred Equity | -- | -- | 162.15M | 162.15M | 162.15M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 51.57M | 63.14M | 3.17M | 15.03M | 38.42M |
|
|
|||||